| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.8M | — | +48.2% |
| Cost of Revenue | $11.4M | — | +32.6% |
| Gross Profit | $2.4M | — | +241.6% |
| R&D Expense | $2.7M | — | +122.4% |
| SG&A Expense | $4.9M | — | -46.2% |
| Operating Income | -$6.9M | — | +41.7% |
| Pre-tax Income | -$7.0M | — | +72.6% |
| Income Tax | $26K | — | +225.0% |
| Net Income | -$7.0M | — | +72.5% |
| EPS (Basic) | -$0.28 | — | -115.4% |
| EPS (Diluted) | -$0.28 | — | -115.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.6M | -57.5% | +328.0% |
| Accounts Receivable | $6.7M | +7.5% | +47.3% |
| Inventory | $28.1M | +3.8% | -39.1% |
| Current Assets | $65.2M | -18.7% | +5.5% |
| Total Assets | $92.4M | -12.3% | +1.1% |
| Current Liabilities | $26.6M | -21.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.0M | — | -45.6% |
| Capital Expenditures | $940K | — | — |
| Investing Cash Flow | -$940K | — | — |
| Financing Cash Flow | -$3.5M | — | -123.6% |
| Free Cash Flow | -$18.9M | — | -53.2% |
| -39.4% |
| Long-term Debt | $9.2M | -70.4% | -57.7% |
| Total Liabilities | $40.9M | -39.2% | -30.2% |
| Stockholders' Equity | $51.5M | +35.1% | +56.7% |